Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 ...

The report is the latest indictment of America’s broken healthcare system.

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price ...

WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...